Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective Yu-Chi ChenWei ShiJin-Jian Lu Review – Cancer Research 05 October 2021 Pages: 1 - 14
Molecular classification of hepatocellular carcinoma: prognostic importance and clinical applications Aroosha RajaFarhan Haq Review – Cancer Research 08 October 2021 Pages: 15 - 29
Estimating the global burden of Epstein–Barr virus-related cancers Yide WongMichael T. MeehanJohn J. Miles Review – Cancer Research Open access 27 October 2021 Pages: 31 - 46
CMTM6, a potential immunotherapy target Jie LiangShaohua LiBei Zhang Review – Cancer Research 16 November 2021 Pages: 47 - 56
Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance Zahra ZandiBahareh KashaniMajid Momeny Review – Cancer Research 04 January 2022 Pages: 57 - 70
GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation Simona Jurkovic MlakarSatyanarayana Chakradhara Rao Uppugundurithe paediatric diseases working party of the European society for blood and marrow transplantation Original Article – Cancer Research Open access 09 September 2021 Pages: 71 - 86
Correction to: GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation Simona Jurkovic MlakarSatyanarayana Chakradhara Rao Uppugundurithe paediatric diseases working party of the European society for blood and marrow transplantation Correction Open access 30 October 2021 Pages: 87 - 88
Post-operative hypofractionated radiotherapy for prostate cancer: a mono-institutional analysis of toxicity and clinical outcomes Giuseppe FerreraSalvatore D’AlessandroAntonio Lo Casto Original Article – Cancer Research 30 September 2021 Pages: 89 - 95
Intra- and peritumoral radiomics on assessment of breast cancer molecular subtypes based on mammography and MRI Shuxian NiuWenyan JiangXiran Jiang Original Article – Cancer Research 08 October 2021 Pages: 97 - 106
Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact Débora Cabral de Carvalho CorrêaFrancine Tesser-GambaSilvia Regina Caminada de Toledo Original Article – Cancer Research 09 October 2021 Pages: 107 - 119
Protective effects of all-trans retinoic acid against gastric premalignant lesions by repressing exosomal LncHOXA10–pyruvate carboxylase axis Chen WangDidi ZhaoQihong Zhao Original Article – Cancer Research 10 October 2021 Pages: 121 - 135
Phosphorylation of CAP1 regulates lung cancer proliferation, migration, and invasion Jie ZengXuan LiChanghui Wang Original Article – Cancer Research Open access 12 October 2021 Pages: 137 - 153
Health and life insurance-related problems in very long-term cancer survivors in Germany: a population-based study Melissa S. Y. ThongDaniela DoegeVolker Arndt Original Article – Cancer Research Open access 13 October 2021 Pages: 155 - 162
Therapeutic exploration of uncommon EGFR exon 20 insertion mutations in advanced non-small cell lung cancer: breaking through brambles and thorns Rilan BaiXiao ChenJiuwei Cui Review – Clinical Oncology 26 October 2021 Pages: 163 - 176
Anti-CD19 monoclonal antibodies for the treatment of relapsed or refractory B-cell malignancies: a narrative review with focus on diffuse large B-cell lymphoma Pier Luigi ZinzaniGiorgio Minotti Review – Clinical Oncology Open access 06 November 2021 Pages: 177 - 190
Propensity-score matched analysis of the efficacy of maintenance/continuous therapy in newly diagnosed patients with multiple myeloma: a multicenter retrospective collaborative study of the Japanese Society of Myeloma Shuji OzakiHiroshi HandaKazuyuki Shimizu Original Article – Clinical Oncology 02 June 2021 Pages: 191 - 203
R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement Maximilian J. SteinhardtFranziska C. KrummenastJohannes Duell Original Article – Clinical Oncology Open access 03 June 2021 Pages: 205 - 214
Role of F-18 FDG PET/CT in the follow-up of asymptomatic renal cell carcinoma patients for postoperative surveillance: based on conditional survival analysis Sohyun ParkHo-Young LeeSangchul Lee Original Article – Clinical Oncology 09 June 2021 Pages: 215 - 224
Survival predictors of 177Lu-Dotatate peptide receptor radionuclide therapy (PRRT) in patients with progressive well-differentiated neuroendocrine tumors (NETS) Mina M. SwihaDuncan E. K. SutherlandDavid T. Laidley Original Article – Clinical Oncology Open access 10 June 2021 Pages: 225 - 236
3D mixed-reality visualization of medical imaging data as a supporting tool for innovative, minimally invasive surgery for gastrointestinal tumors and systemic treatment as a new path in personalized treatment of advanced cancer diseases Ryszard WierzbickiMaria PawłowiczAndrzej Skalski Original Article – Clinical Oncology Open access 10 June 2021 Pages: 237 - 243
Living donor liver transplantation for advanced hepatocellular carcinoma including macrovascular invasion Abu Bakar Hafeez BhattiWajih NaqviAtif Rana Original Article – Clinical Oncology Open access 12 June 2021 Pages: 245 - 253
Association of recipient and donor interleukin 6 polymorphisms 174 and 597 with outcome after allogeneic hematopoietic stem cell transplantation in children Laura WetzelSusan WittigBernd Gruhn Original Article – Clinical Oncology Open access 12 June 2021 Pages: 255 - 265
Aberrant expression and genetic alteration of c-MYC in anaplastic large cell lymphoma Zhenwen ChenFei ChaiXiaoai Tian Original Article – Clinical Oncology 16 June 2021 Pages: 267 - 278
Correction to: Patterns of glioblastoma treatment and survival over a 16-years period: pooled data from the German Cancer Registries Ljupcho EfremovSemaw Ferede AberaDaniel Medenwald Correction 13 April 2021 Pages: 279 - 279
Correction to: Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified Takahiro OtaKeisuke KiritaKoichi Goto Correction 23 July 2021 Pages: 281 - 282